{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:33:37Z","timestamp":1791063217264,"version":"4.1.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.neurobiolaging.2005.03.029","type":"journal-article","created":{"date-parts":[[2005,8,3]],"date-time":"2005-08-03T20:49:16Z","timestamp":1123102156000},"page":"773.e1-773.e3","source":"Crossref","is-referenced-by-count":18,"title":["Lack of association between the CYP46 gene polymorphism and Italian late-onset sporadic Alzheimer's disease"],"prefix":"10.1016","volume":"27","author":[{"given":"Andrea","family":"Tedde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Rotondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Cellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Muratore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Nacmias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Sorbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2005.03.029_bib1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.neurobiolaging.2003.08.004","article-title":"Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer disease: from risk factors to disease modulators","volume":"25","author":"Borroni","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2005.03.029_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0304-3940(02)00443-3","article-title":"Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease","volume":"328","author":"Desai","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.03.029_bib3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00439-004-1107-9","article-title":"Variants of CYP46A1 may interact with age and APOE to influence CSF A\u03b2-42 levels in Alzheimer's disease","volume":"114","author":"Johansson","year":"2004","journal-title":"Hum Genet"},{"key":"10.1016\/j.neurobiolaging.2005.03.029_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neulet.2004.03.066","article-title":"Exclusion of CYP46 and APOM as candidate genes for Alzheimer's disease in a French population","volume":"363","author":"Kabbara","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.03.029_bib5","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/sj.mp.4001109","article-title":"Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease","volume":"7","author":"Kolsch","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2005.03.029_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/MN:27:1:1","article-title":"The role of cholesterol in pathogenesis of Alzheimer's disease: dual metabolic interaction between amyloid beta-protein and cholesterol","volume":"27","author":"Michikawa","year":"2003","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neurobiolaging.2005.03.029_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneur.60.1.29","article-title":"Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism","volume":"60","author":"Papassotiropoulos","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2005.03.029_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1001\/archneur.60.1.16","article-title":"Cyp46 (24S-cholesterol hydroxylase): a genetic risk factor for Alzheimer disease","volume":"60","author":"Wolozin","year":"2003","journal-title":"Arch Neurol"},{"issue":"Suppl. 2","key":"10.1016\/j.neurobiolaging.2005.03.029_bib9","first-page":"S144","article-title":"Cholesterol trafficking and amyloid beta peptides","author":"Wood","year":"2003","journal-title":"Pharmacopsychiatry"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458005001636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458005001636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T02:56:20Z","timestamp":1548298580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458005001636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0197458005001636"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.03.029","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}